Johnson & Johnson (JNJ)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$211.15

Buy

$215.00

arrow-up$1.57 (+0.75%)

Prices updated at 13 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	85,159m	88,821m
	58,606m	61,350m
	23,409m	22,149m
	27.49	24.94
	35,153m	14,066m
	23,320m	24,781m
Sales, General and administrative	20,112m	21,969m
Interest expenses	772m	755m
Provision for income taxes	1,736m	2,621m
Operating expenses	35,197m	39,201m
Income before taxes	15,062m	16,687m
Net income available to common shareholders	35,153m	14,066m
	13.88	5.84
Net interest income	489m	577m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	13.72	5.79
Free cash flow per share	6.0161	7.8293
Book value/share	29.5911	29.1484
Debt equity ratio	0.37632	0.428745

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	53,495m	55,893m
Current liabilities	46,282m	50,321m
Total capital	94,655m	102,141m
Total debt	29,332m	36,634m
Total equity	68,774m	71,490m
Total non current liabilities	-	-
Loans	25,881m	30,651m
Total assets	167,558m	180,104m
Total liabilities	-	-
Cash and cash equivalents	21,859m	24,105m
Common stock	2,407m	2,407m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	14,127m	21,859m
Cash dividends paid	-11,770m	-11,823m
	17,778m	18,059m
Investments (gains) losses	878m	-18,599m
	21,859m	24,105m
Net income	-	-
	22,791m	24,266m
	-5,013m	-6,207m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.